The latest price target for Ocean Biomedical (NASDAQ:OCEA) was reported by Taglich Brothers on May 31, 2023. The analyst firm set a price target for $20.00 expecting OCEA to rise to within 12 months (a possible 3162.11% upside). 0 analyst firms have reported ratings in the last year.

The latest analyst rating for Ocean Biomedical (NASDAQ:OCEA) was provided by Taglich Brothers, and Ocean Biomedical initiated their speculative buy rating.

There is no last upgrade for Ocean Biomedical

There is no last downgrade for Ocean Biomedical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocean Biomedical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocean Biomedical was filed on May 31, 2023 so you should expect the next rating to be made available sometime around May 31, 2024.

While ratings are subjective and will change, the latest Ocean Biomedical (OCEA) rating was a initiated with a price target of $0.00 to $20.00. The current price Ocean Biomedical (OCEA) is trading at is $0.61, which is within the analyst’s predicted range.